Article info
What neurologists need to understand outside their own speciality
Autoinflammatory syndromes in neurology: when our first line of defence misbehaves
- Correspondence to Dr William K Diprose, Department of Neurology, Auckland City Hospital, Auckland 1023, New Zealand; william.diprose{at}auckland.ac.nz
Citation
Autoinflammatory syndromes in neurology: when our first line of defence misbehaves
Publication history
- Accepted September 9, 2021
- First published October 1, 2021.
Online issue publication
March 17, 2022
Article Versions
- Previous version (1 October 2021).
- Previous version (21 October 2021).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Familial Mediterranean fever (FMF) and beyond: a new horizon. Fourth International Congress on the Systemic Autoinflammatory Diseases held in Bethesda, USA, 6–10 November 2005
- Classification criteria for autoinflammatory recurrent fevers
- The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist
- Autoinflammatory diseases: update on classification diagnosis and management
- Visual loss with chronic meningeal and systemic inflammation
- Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study
- Cutaneous signs and mechanisms of inflammasomopathies
- Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers
- Inheritance of autoinflammatory diseases: shifting paradigms and nomenclature
- Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features